FTK-B Reports 2024 Operational Results
First Tracks Biotherapeutics reported 2024 results highlighting adjusted_cash_flow_of_0_and_a_research_collaboration_agreement_with_Genentech,_marking_milestones_in_cytokine_drag_program_progression_and_academic_partnerships.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed